ArticleKidney international reports2020

Study Design of the Phase 3 Sparsentan Versus Irbesartan (DUPLEX) Study in Patients With Focal Segmental Glomerulosclerosis.

Radko Komers et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.